


Beviglia Cancer Models
Biotechnology Research • San Francisco Bay Area, United States • 1-10 Employees
Company overview
| Headquarters | San Francisco Bay Area, United States |
| Phone number | +16502198991 |
| Website | |
| NAICS | 541714 |
| Keywords | Antibodies, Car-T Cells, Circulating And Disseminated Tumor Cell Models, Immuno-Oncology Models, Immunomodulators, In Vivo Angiogenesis Models, In Vivo Assay Of Cancer Stem Cells, In Vivo Efficacy Testing Of Small Molecules, In Vivo Imaging Of Cancer Progression, In Vivo Mtd And Pk Studies, Orthotopic Tumor Models, Translational Medicine Modeling, Tumor Metastasis, Tumor Pharmacology Modeling, Vascular Leakage Syndrome Models, Management And Monitoring Of Contracted Studies, Syngenicmodels |
| Founded | 2018 |
| Employees | 1-10 |
Key Contact at Beviglia Cancer Models
Lucia Beviglia
President and Founder
Beviglia Cancer Models Email Formats
Beviglia Cancer Models uses 1 email format. The most common is {first name} (e.g., john@bevigliacancermodels.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@bevigliacancermodels.com | 100% |
About Beviglia Cancer Models
Our mission is to help biopharma and biotech conduct high quality in vivo preclinical testing of newly discovered anti-cancer treatments in support of R&D project goals and timelines. Beviglia Cancer Models (BCM) is highly sensitive to Client's project goals, expectations, and timelines and fully available to work in an absolutely unique collaborative fashion while maintaining high level of confidentiality. BCM ensures that the progress of each experiment is followed closely and communicated with the Client immediately on a daily basis to enable any necessary and timely revision of the experimental design and changes to avoid missing important results. BCM offers also monitoring capabilities of studies contracted out to facilitate both project execution and delivery of results releasing Directors and VPs from the burden and time-consuming task of overseeing studies done at contract facilities. The President of BCM is always available to help with project and problem solving needs and is continuously striving to build long-term relationships with Clients; is highly motivated, trusted visionary “out of the box” very reliable, transparent, honest, and persistent, adds always care and personal touch to any contract work, and develops a sense of accountability toward the Clients. During her career, the President and Manager has successfully made significant contributions to advancement of drug lead candidates from discovery to clinical development. During the past years she has helped a number of investigators to advance their research by providing reliable and reproducible data through the provided services; those data were utilized for filing patents, presentations at scientific meetings, preparing IND filing prior to clinical trials, presenting to investors, and submitting grant proposals to NIH and other agencies. Her knowledge, skills, creativity, scientific rigor and diligence are key features in all services provided.
Beviglia Cancer Models revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Beviglia Cancer Models has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Beviglia Cancer Models has never raised funding before.
Beviglia Cancer Models Tech Stack
Discover the technologies and tools that power Beviglia Cancer Models's digital infrastructure, from frameworks to analytics platforms.
Form builders
JavaScript libraries
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Programming languages
Hosting
Blogs
WordPress themes
Performance
Frequently asked questions
4.8
40,000 users



